China NMPA Product Recall - Portable oxygen concentrator

On March 4, 2020, Philips (China) Investment Co., Ltd. initiated a voluntary Class III recall of its SimplyGo portable oxygen concentrators, following a notification from the National Medical Products Administration (NMPA) of China. The primary issue identified was a significant discrepancy in the device's audible sound level. While the product's instruction manual stated a maximum sound level of 43 dB(A), NMPA testing independently measured the maximum audible sound level at 53 dB(A). This finding indicated that the device did not conform to the established product requirements and specifications. Philips initiated this recall in response to the non-compliance, citing internal recall document numbers 2020-2-A and 307961897. Despite the technical deviation, the company reported that, as of the recall date, no related injury incidents had been reported globally through their complaint monitoring systems. The regulatory framework for this action falls under the NMPA, which oversees medical device safety and compliance in China. The required action involves the systematic recall of affected portable oxygen concentrator models, specifications, and batches, with further details made available in a Medical Device Recall Event Report Form. This proactive measure by Philips underscores the importance of adherence to product specifications and regulatory oversight by authorities like the NMPA.